Stockholders' Equity - Additional Information (Details)
|
|
|
|
|
|
|
1 Months Ended |
3 Months Ended |
9 Months Ended |
|
|
|
|
|
|
|
|
|
Aug. 29, 2020
item
$ / shares
shares
|
Aug. 28, 2020
USD ($)
$ / shares
shares
|
Aug. 27, 2020
USD ($)
shares
|
Aug. 26, 2020
USD ($)
$ / shares
shares
|
May 29, 2020
USD ($)
$ / shares
shares
|
Feb. 14, 2020
USD ($)
$ / shares
shares
|
Sep. 30, 2020
USD ($)
$ / shares
shares
|
Jun. 30, 2020
USD ($)
$ / shares
shares
|
Sep. 30, 2020
USD ($)
$ / shares
shares
|
Sep. 30, 2019
USD ($)
$ / shares
shares
|
Sep. 30, 2020
USD ($)
$ / shares
shares
|
Sep. 30, 2019
USD ($)
$ / shares
shares
|
Jun. 29, 2020
shares
|
May 31, 2020
USD ($)
|
Mar. 23, 2020
USD ($)
|
Dec. 31, 2019
$ / shares
shares
|
Aug. 16, 2019
USD ($)
|
Jun. 17, 2019
$ / shares
shares
|
Jun. 16, 2019
shares
|
Jul. 13, 2018
USD ($)
|
Nov. 30, 2017
USD ($)
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
|
|
|
|
|
|
$ 3,171,000
|
$ 3,741,000
|
$ 10,319,000
|
$ 10,423,000
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of Series A preferred stock |
|
|
|
|
|
|
|
|
|
|
39,075,000
|
0
|
|
|
|
|
|
|
|
|
|
Proceeds From Issuance Of Preferred Stock, At The Market Offering |
|
|
|
|
|
|
|
|
|
|
$ 0
|
539,000
|
|
|
|
|
|
|
|
|
|
Preferred Stock, Liquidation Preference Per Share | $ / shares |
|
|
|
|
|
|
$ 25.00
|
|
$ 25.00
|
|
$ 25.00
|
|
|
|
|
$ 25.00
|
|
|
|
|
|
Interest Rate |
|
|
|
|
|
|
2.50%
|
|
2.50%
|
|
2.50%
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Shares, Issued | shares |
|
|
|
|
|
|
93,748,374
|
|
93,748,374
|
|
93,748,374
|
|
|
|
|
74,027,425
|
|
150,000,000
|
50,000,000
|
|
|
Common Stock, Par or Stated Value Per Share | $ / shares |
|
|
|
|
|
|
$ 0.001
|
|
$ 0.001
|
|
$ 0.001
|
|
|
|
|
$ 0.001
|
|
$ 0.001
|
|
|
|
Underwriting discounts and commissions and offering expenses |
|
|
|
|
|
|
|
|
|
|
$ 3,407,000
|
0
|
|
|
|
|
|
|
|
|
|
Stock Repurchase Program, Authorized Amount |
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 5,000,000.0
|
$ 5,000,000.0
|
|
|
|
|
|
|
Preferred shares repurchased and held in treasury | shares |
|
|
|
|
|
|
5,000
|
|
5,000
|
|
5,000
|
|
|
|
|
|
|
|
|
|
|
Consideration for repurchase of preferred shares |
|
|
|
|
|
|
|
|
|
|
$ 70,000
|
0
|
|
|
|
|
|
|
|
|
|
Fees incurred for repurchase of preferred shares |
|
|
|
|
|
|
|
|
|
|
$ 2,000
|
0
|
|
|
|
|
|
|
|
|
|
Stock Incentive Plan 2013 [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Shares, Issued | shares |
|
|
|
|
|
|
|
13,000,000.0
|
|
|
|
|
3,000,000.0
|
|
|
|
|
|
|
|
|
Common Stock, Remaining Number of Shares | shares |
|
|
|
|
|
|
|
|
|
|
4,200,000
|
|
|
|
|
|
|
|
|
|
|
Research and Development Expense [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
|
|
|
|
|
|
$ 700,000
|
1,200,000
|
$ 2,500,000
|
2,600,000
|
|
|
|
|
|
|
|
|
|
General and Administrative Expense [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
|
|
|
|
|
|
$ 2,500,000
|
$ 2,500,000
|
$ 7,800,000
|
$ 7,800,000
|
|
|
|
|
|
|
|
|
|
Maximum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Units, Authorized | shares |
|
|
|
|
|
|
150,000,000
|
|
150,000,000
|
|
150,000,000
|
|
|
|
|
|
|
|
|
|
|
Minimum [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Units, Authorized | shares |
|
|
|
|
|
|
50,000,000
|
|
50,000,000
|
|
50,000,000
|
|
|
|
|
|
|
|
|
|
|
2020 Shelf |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock Shares Available For Future Issuance Value |
|
|
|
|
|
|
$ 29,500,000
|
|
$ 29,500,000
|
|
$ 29,500,000
|
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock issued in connection with the first ESPP offering | shares |
|
|
|
|
|
|
|
|
|
|
53,268
|
54,221
|
|
|
|
|
|
|
|
|
|
Issuance of Common Stock for At the Market Offering in shares | shares |
|
|
|
|
|
|
|
|
7,064,214
|
1,213,643
|
16,378,234
|
8,604,469
|
|
|
|
|
|
|
|
|
|
Common Stock [Member] | Market Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Price Per Share | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 2.74
|
|
|
|
|
|
|
|
|
|
|
Proceeds From Issuance Of Preferred Stock, At The Market Offering |
|
|
|
|
|
|
|
|
|
|
$ 44,800,000
|
|
|
|
|
|
|
|
|
|
|
Issuance of Common Stock for At the Market Offering in shares | shares |
|
|
|
|
|
|
|
|
|
|
16,400,000
|
|
|
|
|
|
|
|
|
|
|
Payments for Commissions |
|
|
|
|
|
|
|
|
|
|
$ 1,600,000
|
|
|
|
|
|
|
|
|
|
|
Underwriting discounts and commissions and offering expenses |
|
|
|
|
$ 1,100,000
|
$ 1,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock [Member] | Market Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Price Per Share | $ / shares |
|
|
|
|
$ 18.00
|
$ 20.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock [Member] | 2018 Preferred ATM |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross proceeds |
|
|
|
|
$ 11,500,000
|
$ 14,400,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock [Member] | Over-Allotment Option [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares |
|
64,600
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock [Member] | IPO [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Shares Issued, Price Per Share | $ / shares |
|
$ 25.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Price Per Share | $ / shares |
|
|
|
$ 18.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance Of Preferred Stock For Public Offering | shares |
|
255,400
|
|
666,666
|
555,556
|
625,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock dividends Per Share Cash Paid | $ / shares |
|
$ 0.19531
|
|
|
|
|
|
|
|
|
$ 0.19531
|
|
|
|
|
|
|
|
|
|
|
Annual dividend | $ / shares |
|
2.34375
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock, Liquidation Preference Per Share | $ / shares |
|
$ 25.00
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Preferred stock exchange term optional |
|
24 months
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Initial dividend paid |
|
|
|
|
|
|
|
|
|
|
$ 49,883,000
|
|
|
|
|
|
|
|
|
|
|
Preferred Stock, Dividend Rate, Percentage |
|
|
|
9.375%
|
9.375%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares |
|
|
|
66,666
|
83,333
|
93,750
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate |
|
9.375%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross proceeds |
|
$ 8,000,000.0
|
|
$ 13,200,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Underwriting discounts and commissions and offering expenses |
|
$ 900,000
|
|
$ 1,100,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mustang Bio, Inc [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share Price | $ / shares |
|
|
|
|
|
|
$ 3.56
|
|
$ 3.56
|
$ 6.42
|
$ 3.56
|
$ 6.42
|
|
|
|
|
|
|
|
|
|
Common Stock Shares Available For Future Issuance Value |
|
|
|
|
|
|
$ 32,600,000
|
|
$ 32,600,000
|
|
$ 32,600,000
|
|
|
|
|
|
|
|
|
|
|
Marketable Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 75,000,000.0
|
|
|
$ 75,000,000.0
|
|
Mustang Bio, Inc [Member] | Common Stock [Member] | Market Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Price Per Share | $ / shares |
|
|
|
|
|
|
|
$ 3.25
|
|
|
$ 3.56
|
$ 6.42
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of Common stock |
|
|
|
|
|
|
|
$ 37,200,000
|
|
|
$ 25,600,000
|
$ 22,500,000
|
|
|
|
|
|
|
|
|
|
Proceeds From Issuance Of Common Stock Net of Issuance Costs |
|
|
|
|
|
|
|
$ 34,900,000
|
|
|
$ 25,100,000
|
$ 22,000,000.0
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Shares, New Issues | shares |
|
|
|
|
|
|
|
11,455,604
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Common Stock for At the Market Offering in shares | shares |
|
|
|
|
|
|
|
|
|
|
7,200,000
|
3,500,000
|
|
|
|
|
|
|
|
|
|
Agents Commission, Percentage |
|
|
|
|
|
|
|
|
|
|
3.00%
|
|
|
|
|
|
|
|
|
|
|
Underwriting discounts and commissions and offering expenses |
|
|
|
|
|
|
|
$ 2,300,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mustang Bio, Inc [Member] | Common Stock [Member] | Market Offering [Member] | Founders Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Issuance of Common Stock for At the Market Offering in shares | shares |
|
|
|
|
|
|
|
|
|
|
117,405
|
87,656
|
|
|
|
|
|
|
|
|
|
Checkpoint [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Capital Shares Reserved for Future Issuance | shares |
|
|
|
|
|
|
12,300,000
|
|
12,300,000
|
|
12,300,000
|
|
|
|
|
|
|
|
|
|
|
Marketable Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ 100,000,000
|
Checkpoint [Member] | Common Stock [Member] | Market Offering [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Average Price Per Share | $ / shares |
|
|
|
|
|
|
$ 2.80
|
|
|
|
$ 2.40
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of Common stock |
|
|
|
|
|
|
$ 20,500,000
|
|
|
|
$ 8,700,000
|
|
|
|
|
|
|
|
|
|
|
Proceeds From Issuance Of Common Stock Net of Issuance Costs |
|
|
|
|
|
|
$ 18,900,000
|
|
|
|
$ 8,400,000
|
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Shares, New Issues | shares |
|
|
|
|
|
|
7,321,429
|
|
|
|
3,614,344
|
|
|
|
|
|
|
|
|
|
|
Agents Commission, Percentage |
|
|
|
|
|
|
|
|
|
|
3.00%
|
|
|
|
|
|
|
|
|
|
|
Underwriting discounts and commissions and offering expenses |
|
|
|
|
|
|
$ 1,600,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Checkpoint [Member] | Common Stock [Member] | Market Offering [Member] | Founders Agreement |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average price per share | $ / shares |
|
|
|
|
|
|
|
|
|
|
$ 2.92
|
|
|
|
|
|
|
|
|
|
|
Stock Issued During Period, Shares, New Issues | shares |
|
|
|
|
|
|
|
|
|
|
273,379
|
|
|
|
|
|
|
|
|
|
|
Oaktree Warrants [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares |
1,749,450
|
|
1,749,450
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Purchase price | $ / shares |
$ 3.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percentage of market price |
95.00%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Volatility rate |
0.868%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest Rate |
0.74%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding warrants | shares |
4,800,000
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Financial instruments | item |
2
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value of Warrants |
|
|
$ 4,400,000
|
|
|
|
|
|
|
|
$ 4,400,000
|
|
|
|
|
|
|
|
|
|
|
Warrant expiration term |
10 years
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class of Warrant or Right, Exercise Price of Warrants or Rights | $ / shares |
$ 3.20
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition |
|
|
|
|
|
|
|
|
|
|
3 years 10 months 24 days
|
|
|
|
|
|
|
|
|
|
|
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options |
|
|
|
|
|
|
$ 17,500,000
|
|
$ 17,500,000
|
|
$ 17,500,000
|
|
|
|
|
|
|
|
|
|
|
Restricted Stock Units (RSUs) [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition |
|
|
|
|
|
|
|
|
|
|
|
5 years
|
|
|
|
|
|
|
|
|
|
Employee Service Share-based Compensation, Nonvested Awards, Compensation Not yet Recognized, Stock Options |
|
|
|
|
|
|
|
|
|
$ 12,700,000
|
|
$ 12,700,000
|
|
|
|
|
|
|
|
|
|
Restricted Stock Units (RSUs) [Member] | Mustang Bio, Inc [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjustments To Additional Paid In Capital At Market Offering Costs |
|
|
|
|
|
|
|
|
|
|
$ 500,000
|
500,000
|
|
|
|
|
|
|
|
|
|
Options to Purchase Common Stock [Member] | Employee Stock [Member] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share-based Compensation Arrangement by Share-based Payment Award [Line Items] |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee Stock Purchase Plan to eligible employees, Reckoning fair value percentage during offering period |
|
|
|
|
|
|
85.00%
|
|
85.00%
|
|
85.00%
|
|
|
|
|
|
|
|
|
|
|
Common Stock issued in connection with the first ESPP offering | shares |
|
|
|
|
|
|
|
|
|
|
507,783
|
|
|
|
|
|
|
|
|
|
|
Common Stock, Capital Shares Reserved for Future Issuance | shares |
|
|
|
|
|
|
492,217
|
|
492,217
|
|
492,217
|
|
|
|
|
|
|
|
|
|
|
Stock-based compensation expense |
|
|
|
|
|
|
|
|
$ 38,000
|
$ 18,000
|
$ 100,000
|
$ 100,000
|
|
|
|
|
|
|
|
|
|